HAWK Extension Study: Safety and Efficacy of Intravitreal Brolucizumab in Neovascular Age-related Macular Degeneration-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

HAWK Extension Study: Safety and Efficacy of Intravitreal Brolucizumab in Neovascular Age-related Macular Degeneration

Published:2022-11-18 Issue:1 Volume:48 Page:44-50
ISSN:0271-3683
Container-title:Current Eye Research
language:en
Short-container-title:Current Eye Research

Author:

Brown David M.¹,Nowik Marta²,Bouillaud Emmanuel²,Dugel and Pravin U.³⁴,

Affiliation:

1. Retina Consultants of Texas, Houston, TX, USA

2. Novartis Pharma AG, Basel, Switzerland

3. Retinal Consultants of Arizona, Phoenix, ARI, USA

4. USC Roski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA

Funder

Novartis Pharma AG

Publisher

Informa UK Limited

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Link

https://www.tandfonline.com/doi/pdf/10.1080/02713683.2022.2096907

Reference10 articles.

1. The Prevalence of Age-Related Macular Degeneration in Asians

2. Forecasting Age-Related Macular Degeneration Through the Year 2050

3. Risk factors for age-related macular degeneration

4. Incidence of Legal Blindness From Age-Related Macular Degeneration in Denmark: Year 2000 to 2010

5. Impact of Availability of Anti–Vascular Endothelial Growth Factor Therapy on Visual Impairment and Blindness Due to Neovascular Age-Related Macular Degeneration

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety of recent ophthalmic drugs and devices for wet macular degeneration;Current Opinion in Ophthalmology;2023-05-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP